S&C maintained its “Elite” ranking in New York and received upgraded “Highly Recommended” status in Washington, D.C. in Global Competition Review’s 2018 GCR 100 rankings. GCR highlighted the Firm’s antitrust work on some of the year’s largest and most significant transactions, including Bayer’s $66 billion pending acquisition of Monsanto and Praxair’s $67 billion pending merger of equals with Linde. The publication also noted the Washington, D.C. office’s of hiring Renata Hesse, former U.S. Department of Justice antitrust chief, and promotion of Joseph Matelis, who has Antitrust Division experience, to the partnership.